NewsRoom 2007

Dec 26, 2007 Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO
Dec 07, 2007 Access Pharmaceuticals Demonstrates Ability To Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin™ Oral Insulin
Dec 03, 2007 Access Pharmaceuticals’ ProLindac™ to be Featured at the 10th International Symposium on Platinum Coordination Compounds in Cancer Chemotherapy Conference
Nov 08, 2007 Access Pharmaceuticals Announces $19.5 Million Recapitalization
Oct 31, 2007 Access Pharmaceuticals to Present at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference
Oct 29, 2007 Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac™ at the AACR-NCI-EORTC “Molecular Targets and Cancer Therapeutics” Conference
Oct 24, 2007 Access Pharmaceuticals Announces Presentation on ProLindac™ Phase 2 Study at AACR-NCI-EORTC “Molecular Targets and Cancer Therapeutics” Conference
Oct 10, 2007 Access Pharmaceuticals To Present Data on ProLindac™ at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Sep 17, 2007 Access Highlighted in Recent BusinessWeek Article
Sep 05, 2007 Access and Somanta Announce New Data on Angiolix® Humanized Monoclonal Antibody
Aug 28, 2007 Access and SpePharm Announce Licensing of MuGard™ for Europe
Aug 20, 2007 Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Aug 01, 2007 Access Pharmaceuticals Appoints Esteban Cvitkovic, M.D. as Senior Director, Oncology Clinical R&D
Jun 04, 2007 Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
Apr 27, 2007 Access Pharmaceuticals Announces Expansion of ProLindac™ Clinical Trial Sites
Apr 19, 2007 Access Pharmaceuticals Signs Definitive Merger Agreement with Somanta Pharmaceuticals
Apr 16, 2007 Access Pharmaceuticals Announces Poster Presentations on ProLindac™ at the American Association for Cancer Research 2007 Annual Meeting
Feb 22, 2007 Access Pharmaceuticals Signs Letter of Intent to Acquire Somanta Pharmaceuticals
Feb 22, 2007 Access Pharmaceuticals Announces Presentation of ProLindac™ Data at International Conference
Feb 08, 2007 Access Pharmaceuticals Appoints Esteban Cvitkovic, M.D. as Director and Vice Chairman (Europe)
Jan 30, 2007 Access Pharmaceuticals Issued New ProLindac™ Patent
Jan 22, 2007 Access Pharmaceuticals Receives MuGard™ Patent Allowance
Jan 08, 2007 Access Pharmaceuticals Names Stephen R. Seiler
as President and CEO.